Clinico-pathological factors associated with radioiodine refractory differentiated thyroid carcinoma status.
Schubert L, Mbekwe-Yepnang AM, Wassermann J, Braik-Djellas Y, Jaffrelot L, Pani F, Deniziaut G, Lussey-Lepoutre C, Chereau N, Leenhardt L, Bernier MO, Buffet C.
Schubert L, et al.
J Endocrinol Invest. 2024 Apr 5. doi: 10.1007/s40618-024-02352-z. Online ahead of print.
J Endocrinol Invest. 2024.
PMID: 38578580